Could a simple pill combo prevent preterm birth? new trial aims to find out
NCT ID NCT07337655
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial tests whether taking daily low-dose aspirin and lansoprazole can prevent preterm birth in pregnant women at high risk. The study uses a special screening method to identify those most likely to benefit. About 670 women will be enrolled, taking the medication from early pregnancy until delivery, and researchers will compare their outcomes to those receiving standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-dose aspirin and lansoprazole
- What this could lead to
- If it works, this could provide a new, safe way to prevent preterm birth in high-risk pregnancies, reducing complications for both mother and baby.
- What could go wrong
- This is an early-stage trial (Phase II/III) with 670 participants, so results may not apply to all women. The combination may not reduce preterm birth rates or could cause side effects like gastrointestinal issues.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-TERM BIRTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
Palo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.